References
- Agarwala SS, Thompson JF, Smithers BM, et al. (2012). Immuno-chemoablation of metastatic melanoma with intralesional rose bengal. Ann Oncol 23(suppl 9):371
- Cheng Y, Prusoff WH. (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–108
- Delprat GD JR. (1923). Studies on liver function: rose bengal elimination from the blood as influenced by liver injury. Arch Intern Med 32:401–10
- Furumiya K, Mizutani T. (2008). Inhibition of human CYP3A4, UGT1A6, and P-glycoprotein with halogenated xanthene food dyes and prevention by superoxide dismutase. J Toxicol Environ Health A 71:1307–13
- Haupt LJ, Kazmi F, Smith BD, et al. (2011). Can Ki values for direct inhibition of CYP enzymes be reliably estimated from IC50 values? Drug Metab Rev 43(suppl 2):105
- Haupt LJ, Yerino P, Ogilvie BW, et al. (2009). Optimization of in vitro UGT inhibition studies. Drug Metab Rev 41(suppl 3):93–4
- Kellogg EW 3rd, Fridovich I. (1975). Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 250:8812–17
- Kim SY, Tak JK, Park JW. (2004). Inactivation of NADP(+)-dependent isocitrate dehydrogenase by singlet oxygen derived from photoactivated rose bengal. Biochimie 86:501–7
- Kochevar IE, Redmond RW. (2000). Photosensitized production of singlet oxygen. In: Packer L, Sies H, eds. Methods in enzymology: singlet oxygen, UV-A, and ozone. San Diego (CA): Academic Press, 20–8
- Kubin RH, Grodsky GM, Carbone JV. (1960). Investigation of rose bengal conjugation. Proc Soc Exp Biol Med 104:650–3
- Millburn P. (1970). Factors in the biliary excretion of organic compounds. In: Fishman W, ed. Metabolic conjugation and metabolic hydrolysis. New York: Academic Press, 1–70
- Neckers DC. (1989). Rose bengal. J Photochem Photobiol A Chem 47:1–29
- Ogilvie BW, Usuki E, Yerino P, Parkinson A. (2008). In vitro approaches for studying the inhibition of drug-metabolizing enzymes and identifying the drug-metabolizing enzymes responsible for the metabolism of drugs (reaction phenotyping) with emphasis on cytochrome P450. In: Rodrigues AD, ed. Drug–drug interactions. New York: Informa Healthcare USA Inc., 231–358
- Ogilvie BW, Zhang D, Li W, et al. (2006). Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug–drug interactions. Drug Metab Dispos 34:191–7
- Paris BL, Ogilvie BW, Scheinkoenig JA, et al. (2009). In Vitro inhibition and induction of human liver cytochrome P450 enzymes by milnacipran. Drug Metab Dispos 37:2045–54
- Parkinson A, Kazmi F, Buckley DB, et al. (2010). System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes. Drug Metab Pharmacokinet 25:16–27
- Parkinson A, Kazmi F, Buckley DB, et al. (2011). An evaluation of the dilution method for identifying metabolism-dependent inhibitors (MDIs) of cytochrome P450 (CYP) enzymes. Drug Metab Dispos 39:1370–87
- Parkinson A, Mudra DR, Johnson C, et al. (2004). The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199:193–209
- Parkinson A, Ogilvie BW, Buckley DB, et al. (2013). Biotransformation of xenobiotics. In: Klaassen CD, ed. Casarett & Doull's toxicology: the basic science of poisons. New York: McGraw-Hill, Inc., 185–367
- Pearce RE, Rodrigues AD, Goldstein JA, Parkinson A. (1996). Identification of the human P450 enzymes involved in lansoprazole metabolism. J Pharmacol Exp Ther 277:805–16
- Pirotte J. (1980). Study of 131I-rose bengal kinetics in normal man: a critical evaluation of a three-compartment model. Biomedicine 32:17–21
- Pizzimenti S, Toaldo C, Pettazzoni P, et al. (2010). The “two-faced” effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers 2:338–63
- Robertson P, DeCory HH, Madan A, Parkinson A. (2000). In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil. Drug Metab Dispos 28:664–71
- Thompson JF, Hersey P, Wachter E. (2008). Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma Res 18:405–11
- Toomey P, Kodumudi K, Weber A, et al. (2013). Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer. PLoS One 8:e68561
- Tran TH, Von Moltke LL, Venkatakrishnan K, et al. (2002). Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors. Drug Metab Dispos 30:1441–5
- Uesugi N, Furumiya K, Mizutani T. (2006). Inhibition mechanism of UDP-glucuronosyltransferase 1A6 by xanthene food dyes. J Health Sci 52:549–57
- Wang HK, Miyachi S, Yamazaki M, et al. (1992). Nonlinear pharmacokinetics of hepatobiliary transport of rose bengal in rats after i.v. bolus administration with varying doses. Biopharm Drug Dispos 13:647–62